DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Infergen (Interferon Alfacon-1) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Infergen (Interferon Alfacon-1) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (10)

Reports by Reaction Type

Treatment Failure (4)Pain (2)Neoplasm Progression (2)Multiple Myeloma (2)Refractory Cytopenia With Multilineage Dysplasia (2)Influenza Like Illness (2)Polyneuropathy (2)Stem Cell Transplant (2)Fatigue (2)Obesity (2)Depression (2)Thrombocytopenia (2)

Possible Infergen side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Treatment Failure

Drug(s) suspected as cause:
Infergen

Pegasys

Therapy Unspecified



Possible Infergen side effects in

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient:

Reactions: Treatment Failure

Drug(s) suspected as cause:
Infergen

Rebetol



Possible Infergen side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: 49 year old female, weighing 102.1 kg (224.5 pounds)

Reactions: Pain, Pyrexia, Malaise, Fatigue, Skin Ulcer, Medication Error, Depression, Rash Vesicular, Blood Test Abnormal, Staphylococcal Skin Infection, White Blood Cell Count Decreased, Skin Disorder, Impaired Healing, Asthenia, Mobility Decreased, Influenza Like Illness

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600 mg, 3 days a week, oral, 600 mg in morning and evening, daily
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-05-01

Ribavirin
    Dosage: 600 mg, 3 days a week, oral, 600 mg in morning and evening, daily
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-08

Infergen
    Dosage: treated for wrong genotype 1, 15 mcg/0.5ml, thrice weekly, injection, subcutaneous
    Indication: Hepatitis C
    Start date: 2011-05-01

Infergen
    Dosage: treated for wrong genotype 1, 15 mcg/0.5ml, thrice weekly, injection, subcutaneous
    Indication: Hepatitis C
    Start date: 2011-11-08

Other drugs received by patient: Fosamax; Clonazepam; Isoniazid; Bactroban; Topamax; Hibiclens; Oxygen; Prednisone TAB; Calcium / Vitamin D; Methadone HCL; Phenergan HCL; Triamcinolone Acetonide; Motrin; Xanax; Clindamycin Phosphate; Dulera Oral Inhalation; Ventolin



Possible Infergen side effects in 61 year old male

Reported by a physician from United States on 2012-03-21

Patient: 61 year old male

Reactions: Anaemia, Obesity, Treatment Failure, Thrombocytopenia, Polyneuropathy

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Infergen
    Indication: Hepatitis C
    Start date: 2008-01-01

Ribavirin
    Indication: Hepatitis C



Possible Infergen side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Greece on 2011-12-02

Patient: 49 year old male

Reactions: Stem Cell Transplant, Neoplasm Progression, Multiple Myeloma, Refractory Cytopenia With Multilineage Dysplasia

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 10 cycles
    Indication: Multiple Myeloma

Cytarabine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Ifosfamide
    Indication: Multiple Myeloma

Carmustine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Etoposide
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Infergen
    Dosage: 3 x 10 iu thrice weekly
    Indication: Multiple Myeloma
    End date: 2005-09-01

Prednisone TAB
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma



Possible Infergen side effects in 55 year old male

Reported by a physician from United States on 2011-11-25

Patient: 55 year old male, weighing 113.4 kg (249.5 pounds)

Reactions: Listless, Nausea, Chills, Pain of Skin, Bone Pain, Pain, Hyperhidrosis, Feeling Cold, Tremor, Myalgia, Fatigue, Decreased Appetite

Drug(s) suspected as cause:
Infergen
    Dosage: 15 microgram once a day, subcutaneous
    Indication: Hepatitis C
    Start date: 2010-04-21

Ribavirin
    Dosage: 600 mg twice daily, oral
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-04-21



Possible Infergen side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Greece on 2011-11-23

Patient: 49 year old male

Reactions: Stem Cell Transplant, Neoplasm Progression, Refractory Cytopenia With Multilineage Dysplasia, Multiple Myeloma

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Prednisone TAB
    Indication: Multiple Myeloma

Infergen
    Dosage: 3 x 10 iu thrice weekly
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Cytarabine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Carmustine
    Indication: Multiple Myeloma
    Start date: 1998-11-01

Ifosfamide
    Indication: Multiple Myeloma

Cisplatin
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Dosage: 10 cycles
    Indication: Multiple Myeloma



Possible Infergen side effects in 61 year old male

Reported by a physician from United States on 2011-11-02

Patient: 61 year old male

Reactions: Anaemia, Obesity, Treatment Failure, Thrombocytopenia, Polyneuropathy

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    End date: 2008-01-01

PEG-Intron
    Indication: Hepatitis C

Infergen
    Indication: Hepatitis C
    End date: 2008-01-01



Possible Infergen side effects in 58 year old male

Reported by a consumer/non-health professional from United States on 2011-10-19

Patient: 58 year old male

Reactions: Weight Increased, Muscle Atrophy, Depression

Drug(s) suspected as cause:
Ribavirin
    Indication: Product Used FOR Unknown Indication

Infergen
    Indication: Product Used FOR Unknown Indication



Possible Infergen side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-04

Patient: female

Reactions: Dysarthria, Concussion, Fall, Amnesia, Loss of Consciousness, Influenza Like Illness

Drug(s) suspected as cause:
Ribavirin
    Indication: Hepatitis C
    Start date: 2009-01-01
    End date: 2009-11-01

Infergen
    Indication: Hepatitis C
    Start date: 2009-01-01
    End date: 2009-11-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017